Publication
Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.
Neal D Shore, Hiroyuki Nishiyama, Joan Palou Redorta, Michał Krawczyński, Artur Seyitkuliev, Andrey Novikov, Félix Guerrero-Ramos, Minoru Kato, Lieven Goeman, Eva Hellmis, Thomas Powles, Kilian M Gust, Paul Vasey, Pierre Bigot, Yves Fradet, Robert Zielinski, Julien Deturmeny, Girish Kulkarni, Jarmo Hunting, Purnima Rao-Melacini, Suliman Boulos, Angie K Marsh, Maria De Santis
The Journal of urologyOct 1, 2026PMID 42713893doi:10.1097/JU.0000000000005170 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.